With effect from 1st Dec 2016, esomeprazole, mometasone, olopatadine, and ruscogenins/trimebutine were reclassified as POMs granted exemptions for limited sale and supply without prescription.
This move is in line with H.S.A.’s efforts to further enhance access to effective and safe medicines by the general public.
These selected POMs had been reviewed by H.S.A. that they can be used in a safe and effective manner under the supervision of a pharmacist, subject to conditions including indication, strength, maximum daily dose, maximum supply quantity, and age restriction.
|
Active ingredient |
Exemptions for supply of POM without prescription |
|
|
As an intranasal spray not exceeding 50mcg/actuation |
|
Esomeprazole |
As an oral solid preparation not exceeding 20mg |
|
Olopatadine 0.1% and 0.2% |
As an eyedrop not exceeding 0.2% Maximum daily dose: Maximum supply: Minimum age: 3 years |
|
Ruscogenins and trimebutine |
As a rectal cream not exceeding 0.5g/5.8g per 100g As suppositories not exceeding 10mg/120mg |
Table: New POMs granted exemptions for limited sale and supply without prescription (with effect from 1 Dec 2016)
In the absence of an appropriate consumer pack for the supply of medicine under this exemption, the Pharmaceutical Society of Singapore (PSS) has developed patient information leaflets (PILs) for pharmacists to supply upon dispensing.
The reclassification of medications exercise has been made a regular annual event since January 2016 to shift more medicines to a lower tier of control.
For the full list of Updates on Reclassified Medicines, visit this link:
For the full list of PSS PILs, go to:
Prepared by: Sharene Goh
